How much 7 drugmakers are earning from COVID-19 treatments

Vaccines, antiviral pills and monoclonal antibodies designed to prevent and treat COVID-19 have brought in billions for drugmakers during the pandemic. Here is a breakdown of the amounts seven drugmakers are earning for COVID-19 treatments.